BeOne Medicines (ONC) Net Income Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) Net Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 145.96% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1,228.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,802.13% |
| Dec 31, 2025 | 143.79% |
| Sep 30, 2025 | 202.88% |
| Jun 30, 2025 | 178.34% |
| Mar 31, 2025 | 100.51% |
| Dec 31, 2024 | 58.68% |
| Sep 30, 2024 | -156.33% |
| Jun 30, 2024 | 68.41% |
| Mar 31, 2024 | 27.92% |
| Dec 31, 2023 | 17.47% |
| Sep 30, 2023 | 138.64% |
| Jun 30, 2023 | 32.63% |
| Mar 31, 2023 | 19.94% |
| Dec 31, 2022 | 24.61% |
| Sep 30, 2022 | -27.26% |
| Jun 30, 2022 | -17.78% |
| Mar 31, 2022 | -754.48% |
| Dec 31, 2021 | -17.97% |
| Sep 30, 2021 | -2.69% |
| Jun 30, 2021 | -42.82% |